Great Valley Advisor Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,558
Closed -$441K 1008
2025
Q4
$441K Buy
5,558
+262
+5% +$20.7K 0.01% 665
2025
Q3
$399K Buy
5,296
+7
+0.1% +$480 0.01% 689
2025
Q2
$365K Sell
5,289
-490
-8% -$32.1K 0.01% 690
2025
Q1
$392K Buy
5,779
+605
+12% +$36.2K 0.01% 650
2024
Q4
$232K Sell
5,174
-1,960
-27% -$110K 0.01% 774
2024
Q3
$449K Sell
7,134
-3,597
-34% -$210K 0.01% 587
2024
Q2
$634K Sell
10,731
-10,105
-48% -$632K 0.02% 480
2024
Q1
$1.66M Buy
20,836
+1,793
+9% +$137K 0.05% 300
2023
Q4
$1.5M Buy
19,043
+1,968
+12% +$140K 0.05% 282
2023
Q3
$1.19M Sell
17,075
-1,183
-6% -$83.8K 0.05% 290
2023
Q2
$1.26M Sell
18,258
-1,250
-6% -$88.9K 0.05% 285
2023
Q1
$1.45M Buy
19,508
+780
+4% +$65.4K 0.07% 259
2022
Q4
$1.74M Sell
18,728
-1,447
-7% -$140K 0.09% 235
2022
Q3
$1.92M Sell
20,175
-399
-2% -$39.5K 0.11% 201
2022
Q2
$1.91M Buy
20,574
+12,846
+166% +$1.25M 0.1% 201
2022
Q1
$786K Sell
7,728
-757
-9% -$79.5K 0.05% 312
2021
Q4
$837K Buy
8,485
+154
+2% +$14.2K 0.05% 288
2021
Q3
$707K Buy
8,331
+362
+5% +$30.3K 0.05% 293
2021
Q2
$649K Buy
7,969
+95
+1% +$7.78K 0.05% 293
2021
Q1
$592K Sell
7,874
-632
-7% -$46K 0.06% 274
2020
Q4
$581K Buy
8,506
+1,114
+15% +$72.5K 0.06% 258
2020
Q3
$431K Buy
7,392
+248
+3% +$15.4K 0.05% 278
2020
Q2
$465K Buy
7,144
+878
+14% +$55.3K 0.08% 245
2020
Q1
$372K Sell
6,266
-19
-0.3% -$1.27K 0.1% 214
2019
Q4
$467K Buy
6,285
+1,887
+43% +$132K 0.1% 212
2019
Q3
$277K Sell
4,398
-63
-1% -$3.73K 0.07% 271
2019
Q2
$242K Buy
4,461
+402
+10% +$21.6K 0.06% 287
2019
Q1
$219K Buy
4,059
+390
+11% +$24.1K 0.07% 272
2018
Q4
$240K Buy
+3,669
New +$274K 0.09% 201

Other funds holding CVS

Great Valley Advisor Group's CVS Position: Q1 2026 in Review

Great Valley Advisor Group sold out of CVS Health (CVS) in Q1 2026, closing a stake of 5,558 shares — an estimated $441K sold.

Great Valley Advisor Group first reported a position in CVS in Q4 2018 and held it in 29 quarters. The position peaked at $1.92M in Q3 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Great Valley Advisor Group reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Great Valley Advisor Group sold 5,558 CVS Health shares in Q1 2026, an estimated $441K.
  • Great Valley Advisor Group first reported a position in CVS Health in Q4 2018 and held it in 29 quarters.
  • Great Valley Advisor Group's CVS Health position peaked at $1.92M in Q3 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.